These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 26637848)

  • 1. Innovative Therapeutic Strategies in the Treatment of Meningioma.
    Caruso G; Elbabaa SK; Gonzalez-Lopez P; Barresi V; Passalacqua M; Caffo M
    Anticancer Res; 2015 Dec; 35(12):6391-400. PubMed ID: 26637848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in chemotherapy for meningiomas: a review.
    Moazzam AA; Wagle N; Zada G
    Neurosurg Focus; 2013 Dec; 35(6):E18. PubMed ID: 24289126
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medical treatment of recurrent meningiomas.
    Chamberlain MC; Barnholtz-Sloan JS
    Expert Rev Neurother; 2011 Oct; 11(10):1425-32. PubMed ID: 21955199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic meningioma: octreotide therapy for a case of recurrent and progressive intracranial disease.
    Rammo R; Rock A; Transou A; Raghunathan A; Rock J
    J Neurosurg; 2016 Feb; 124(2):496-500. PubMed ID: 26274993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the therapeutic approaches to brain tumors.
    Lallana EC; Abrey LE
    Expert Rev Anticancer Ther; 2003 Oct; 3(5):655-70. PubMed ID: 14599089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted drug therapy for meningiomas.
    Norden AD; Drappatz J; Wen PY
    Neurosurg Focus; 2007; 23(4):E12. PubMed ID: 17961036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New molecular targets in meningiomas: the present and the future.
    Venur VA; Santagata S; Galanis E; Brastianos PK
    Curr Opin Neurol; 2018 Dec; 31(6):740-746. PubMed ID: 30379704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of a meningioma during paclitaxel and bevacizumab therapy for breast cancer.
    Wilson TJ; Heth JA
    J Clin Neurosci; 2012 Mar; 19(3):468-9. PubMed ID: 22245272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy: What is its role in meningioma?
    Sherman WJ; Raizer JJ
    Expert Rev Neurother; 2012 Oct; 12(10):1189-95; quiz 1196. PubMed ID: 23082735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stabilization of disease progression by hydroxyurea in patients with recurrent or unresectable meningioma.
    Mason WP; Gentili F; Macdonald DR; Hariharan S; Cruz CR; Abrey LE
    J Neurosurg; 2002 Aug; 97(2):341-6. PubMed ID: 12186462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hydroxyurea for treatment of unresectable and recurrent meningiomas. I. Inhibition of primary human meningioma cells in culture and in meningioma transplants by induction of the apoptotic pathway.
    Schrell UM; Rittig MG; Anders M; Kiesewetter F; Marschalek R; Koch UH; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):845-52. PubMed ID: 9126901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea.
    Schrell UM; Rittig MG; Anders M; Koch UH; Marschalek R; Kiesewetter F; Fahlbusch R
    J Neurosurg; 1997 May; 86(5):840-4. PubMed ID: 9126900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade meningiomas: new avenues for drug treatment?
    Preusser M; Berghoff AS; Hottinger AF
    Curr Opin Neurol; 2013 Dec; 26(6):708-15. PubMed ID: 24184974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraarterial cisplatin plus intravenous doxorubicin for inoperable recurrent meningiomas.
    Stewart DJ; Dahrouge S; Wee M; Aitken S; Hugenholtz H
    J Neurooncol; 1995; 24(2):189-94. PubMed ID: 7562006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of Atypical and Anaplastic Meningiomas: Classification, Molecular Biology, and Management.
    Wilson TA; Huang L; Ramanathan D; Lopez-Gonzalez M; Pillai P; De Los Reyes K; Kumal M; Boling W
    Front Oncol; 2020; 10():565582. PubMed ID: 33330036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging systemic treatment options in meningioma.
    Mair MJ; Berghoff AS; Brastianos PK; Preusser M
    J Neurooncol; 2023 Jan; 161(2):245-258. PubMed ID: 36181606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel Advances in Treatment of Meningiomas: Prognostic and Therapeutic Implications.
    Caruso G; Ferrarotto R; Curcio A; Metro L; Pasqualetti F; Gaviani P; Barresi V; Angileri FF; Caffo M
    Cancers (Basel); 2023 Sep; 15(18):. PubMed ID: 37760490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated extracranial metastatic meningioma.
    Chua FH; Low SY; Tham CK; Ding C; Wong CF; Nolan CP
    J Clin Neurosci; 2016 Nov; 33():214-216. PubMed ID: 27515545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacotherapeutic options for atypical meningiomas.
    Ahsan SA; Chendeb K; Profyris C; Teo C; Sughrue ME
    Expert Opin Pharmacother; 2019 Oct; 20(15):1831-1836. PubMed ID: 31322413
    [No Abstract]   [Full Text] [Related]  

  • 20. Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition.
    Gupta V; Samuleson CG; Su S; Chen TC
    Neurosurg Focus; 2007; 23(4):E9. PubMed ID: 17961046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.